All In Biotech

Free tool

FAERS Monitor: Succinylcholine Chloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215143 or its brand name (Succinylcholine Chloride, Succinylcholine Chloride). Reports on generic versions are filed under their own applications.

Reports

2,012

Serious

1,725

86% of reports

Hospitalization

696

Death reported

234

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective232
  • hypotension177
  • cardiac arrest160
  • anaphylactic shock146
  • drug interaction126
  • anaphylactic reaction111
  • renal failure99
  • renal impairment99
  • hyperthermia malignant98
  • pain96
  • maternal exposure during pregnancy91
  • injury87
  • anxiety85
  • rhabdomyolysis81
  • unevaluable event79

Reports by year received

View as table
YearReports
200491
200529
200640
200748
200844
200954
201071
2011190
201290
201327
201422
201544
201667
201793
201885
2019148
2020148
2021125
2022124
2023122
2024105
2025159
202686

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,147 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperthermia malignantSignal98737.2603.566,624
anaphylactic shockSignal14659.550.98,309
anaphylactic reactionSignal11121.017.62,100
rhabdomyolysisSignal8120.316.41,471
cardiac arrestSignal16020.317.52,922
injurySignal8713.010.5950
renal impairmentSignal9912.310.21,023
unevaluable eventSignal7910.98.8704
maternal exposure during pregnancySignal9110.78.7792
hypotensionSignal1779.28.01,302
drug interactionSignal1268.37.0808
renal failureSignal997.86.4583
anxietySignal853.12.5122
drug ineffective2321.81.694
pain961.61.324

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.